Company / Net Income
VitaNova Life Sciences Corp Net Income History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$850.7K
FY2024
5-year range
-$24.2K / $850.7K
FY2020-FY2024
Trend
+503.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income changed +504% YoY in FY2024, a notable deviation from the 6-year average annual change of +249%.
Based on SEC 10-K filings.
$850,746 in FY2024 with a 3-year CAGR of +82.6%.
Improved from -$24,227 to $850,746 over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- +82.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +82.6%, indicating consistent growth.
- In FY2024, net income increased 503.9% year-over-year.
- Lowest net income in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $850.7K | +503.9% |
| FY2023 | $140.9K | +681.4% |
| FY2022 | -$24.2K | -117.3% |
| FY2021 | $139.7K | +368.1% |
| FY2020 | -$52.1K | +28.0% |
| FY2019 | -$72.3K | +31.9% |
| FY2018 | -$106.2K | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026